These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 26238495

  • 1. Inhibition of fatty-acid amide hydrolyse (FAAH) exerts cognitive improvements in male but not female rats.
    Hlavacova N, Chmelova M, Danevova V, Csanova A, Jezova D.
    Endocr Regul; 2015 Jul; 49(3):131-6. PubMed ID: 26238495
    [Abstract] [Full Text] [Related]

  • 2. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats.
    Hasanein P, Teimuri Far M.
    Pharmacol Biochem Behav; 2015 Apr; 131():130-5. PubMed ID: 25689415
    [Abstract] [Full Text] [Related]

  • 3. Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.
    Kwilasz AJ, Abdullah RA, Poklis JL, Lichtman AH, Negus SS.
    Behav Pharmacol; 2014 Apr; 25(2):119-29. PubMed ID: 24583930
    [Abstract] [Full Text] [Related]

  • 4. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system.
    Okine BN, Norris LM, Woodhams S, Burston J, Patel A, Alexander SP, Barrett DA, Kendall DA, Bennett AJ, Chapman V.
    Br J Pharmacol; 2012 Oct; 167(3):627-40. PubMed ID: 22595021
    [Abstract] [Full Text] [Related]

  • 5. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, Goldberg SR.
    Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
    [Abstract] [Full Text] [Related]

  • 6. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A, Vozella V, Lim J, Oveisi F, Ramirez GL, Mears D, Wynn G, Piomelli D.
    Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
    Jiang HX, Ke BW, Liu J, Ma G, Hai KR, Gong DY, Yang Z, Zhou C.
    Anesth Analg; 2019 Aug; 129(2):587-597. PubMed ID: 29863609
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
    Seillier A, Advani T, Cassano T, Hensler JG, Giuffrida A.
    Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposure.
    Rivera P, Fernández-Arjona MDM, Silva-Peña D, Blanco E, Vargas A, López-Ávalos MD, Grondona JM, Serrano A, Pavón FJ, Rodríguez de Fonseca F, Suárez J.
    Biochem Pharmacol; 2018 Nov; 157():244-257. PubMed ID: 30098312
    [Abstract] [Full Text] [Related]

  • 10. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
    Bosier B, Muccioli GG, Lambert DM.
    Br J Pharmacol; 2013 Jun; 169(4):794-807. PubMed ID: 22970888
    [Abstract] [Full Text] [Related]

  • 11. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.
    Justinova Z, Mangieri RA, Bortolato M, Chefer SI, Mukhin AG, Clapper JR, King AR, Redhi GH, Yasar S, Piomelli D, Goldberg SR.
    Biol Psychiatry; 2008 Dec 01; 64(11):930-7. PubMed ID: 18814866
    [Abstract] [Full Text] [Related]

  • 12. Effects of the fatty acid amide hydrolase inhibitor URB597 on coping behavior under challenging conditions in mice.
    Haller J, Aliczki M, Pelczer KG, Spitzer K, Balogh Z, Kantor S.
    Psychopharmacology (Berl); 2014 Feb 01; 231(3):593-601. PubMed ID: 24037493
    [Abstract] [Full Text] [Related]

  • 13. The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues.
    Clapper JR, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    Pharmacol Res; 2006 Nov 01; 54(5):341-4. PubMed ID: 16935521
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice.
    Hoyer FF, Khoury M, Slomka H, Kebschull M, Lerner R, Lutz B, Schott H, Lütjohann D, Wojtalla A, Becker A, Zimmer A, Nickenig G.
    J Mol Cell Cardiol; 2014 Jan 01; 66():126-32. PubMed ID: 24286707
    [Abstract] [Full Text] [Related]

  • 15. Long-term administration of fatty acid amide hydrolase inhibitor (URB597) to rats with spontaneous hypertension disturbs liver redox balance and phospholipid metabolism.
    Biernacki M, Ambrożewicz E, Gęgotek A, Toczek M, Skrzydlewska E.
    Adv Med Sci; 2019 Mar 01; 64(1):15-23. PubMed ID: 30243113
    [Abstract] [Full Text] [Related]

  • 16. Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats.
    Panlilio LV, Thorndike EB, Nikas SP, Alapafuja SO, Bandiera T, Cravatt BF, Makriyannis A, Piomelli D, Goldberg SR, Justinova Z.
    Psychopharmacology (Berl); 2016 May 01; 233(10):1879-88. PubMed ID: 26558620
    [Abstract] [Full Text] [Related]

  • 17. Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain.
    Hama AT, Germano P, Varghese MS, Cravatt BF, Milne GT, Pearson JP, Sagen J.
    PLoS One; 2014 May 01; 9(5):e96396. PubMed ID: 24788435
    [Abstract] [Full Text] [Related]

  • 18. Reducing endocannabinoid metabolism with the fatty acid amide hydrolase inhibitor, URB597, fails to modify reinstatement of morphine-induced conditioned floor preference and naloxone-precipitated morphine withdrawal-induced conditioned floor avoidance.
    McCallum AL, Limebeer CL, Parker LA.
    Pharmacol Biochem Behav; 2010 Oct 01; 96(4):496-500. PubMed ID: 20643159
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
    Naidu PS, Varvel SA, Ahn K, Cravatt BF, Martin BR, Lichtman AH.
    Psychopharmacology (Berl); 2007 May 01; 192(1):61-70. PubMed ID: 17279376
    [Abstract] [Full Text] [Related]

  • 20. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.
    Hasanein P, Shahidi S, Komaki A, Mirazi N.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):132-5. PubMed ID: 18593578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.